MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

China Biologic Products Company Profile (NASDAQ:CBPO)

Consensus Ratings for China Biologic Products (NASDAQ:CBPO) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $140.50 (38.17% upside)

Analysts' Ratings History for China Biologic Products (NASDAQ:CBPO)
Show:
DateFirmActionRatingPrice TargetActions
6/4/2016Jefferies GroupReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/1/2016Credit SuisseDowngradeOutperform -> Neutral$129.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Deutsche BankBoost Price TargetBuy$149.00 -> $162.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/9/2015Bank of AmericaInitiated CoverageBuy$135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/3/2014AegisReiterated RatingBuy$55.00 -> $59.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for China Biologic Products (NASDAQ:CBPO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/5/2016        
5/4/2016Q116$0.88$0.94$74.00 million$85.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q415$0.55$0.74$66.77 million$68.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2015Q315$0.81$0.82$75.30 million$78.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215$0.87$1.06$71.75 million$79.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q1 15$0.84$0.87ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/4/2015Q4 14$0.51$0.48ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q114$0.47$0.69$51.40 million$56.27 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/12/2014Q413$0.38$0.35$41.50 million$42.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313$0.42$0.56$47.20 million$53.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2012Q312$0.54$41.30 million$53.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for China Biologic Products (NASDAQ:CBPO)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for China Biologic Products (NASDAQ:CBPO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for China Biologic Products (NASDAQ:CBPO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/8/2016Wp X Biologics LlcDirectorSell2,775,000$111.00$308,025,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Ming YangCFOSell13,908$113.64$1,580,505.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Ming YinVPSell19,618$113.64$2,229,389.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016Zhijing Cbpo LiuVPSell282$108.00$30,456.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Wp X Biologics LlcDirectorSell4,257,000$107.00$455,499,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Zhijun TongDirectorSell15,000$118.33$1,774,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2015David GaoCEOSell95,991$115.60$11,096,559.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015David GaoCEOSell12,891$112.26$1,447,143.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2015David GaoCEOSell71,118$110.21$7,837,914.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/26/2015David GaoCEOSell59,542$105.22$6,265,009.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/20/2015David GaoCEOSell258$105.00$27,090.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/19/2015David GaoCEOSell200$105.03$21,006.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Ming YangCFOSell9,000$94.56$851,040.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2015Ming YinVPSell20,508$95.55$1,959,539.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015Ming YangCFOSell11,304$97.08$1,097,392.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015Wenfang LiuDirectorSell2,717$97.02$263,603.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/14/2015Zhijing Cbpo LiuVPSell6,786$99.29$673,781.94View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Wp X Biologics LlcDirectorSell2,645,000$100.28$265,240,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/21/2014Zhijing Cbpo LiuVPSell8,000$68.95$551,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Sean ShaoDirectorSell72,500$62.75$4,549,375.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Zhijing Cbpo LiuVPSell7,500$62.75$470,625.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Gang Cbpo YangVPSell2,454$54.00$132,516.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Ming YangCFOSell6,164$54.00$332,856.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2014Ming YinVPSell3,073$54.00$165,942.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/12/2013Wenfang LiuDirectorSell2,524$25.00$63,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Wp X Biologics LlcDirectorBuy3,112,920$20.00$62,258,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for China Biologic Products (NASDAQ:CBPO)
DateHeadline
06/25/16 04:07 AMOversold Conditions For China Biologic Products (CBPO) - Nasdaq
06/24/16 03:12 PMOversold Conditions For China Biologic Products (CBPO)
06/20/16 01:09 PMETF’s with exposure to China Biologic Products, Inc. : June 20, 2016 -
06/20/16 09:28 AMChina Biologic Opens Plasma Collection Station in Hebei Province - PR Newswire (press release)
06/20/16 09:28 AMStrong Buy Calls Count For China Biologic Products, Inc. (NASDAQ:CBPO) At 3 - Investor Newswire
06/20/16 07:59 AMChina Biologic Opens Plasma Collection Station in Hebei Province - [at noodls] - BEIJING, June 20, 2016/PRNewswire / -- China Biologic Products, Inc. (NASDAQ: CBPO, 'China Biologic' or the 'Company'), a leading fully integrated plasma-based biopharmaceutical company in China, today ...
06/20/16 07:46 AMCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders, Other Events, -
06/19/16 02:58 PMThis Weeks Broker Views For China Biologic Products, Inc. (NASDAQ:CBPO) - Fiscal Standard
06/14/16 07:23 AMNotable Two Hundred Day Moving Average Cross - CBPO
06/13/16 07:01 AMCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Regulation FD Disclosure -
06/12/16 08:24 PMTrend Of Rating Given To China Biologic Products, Inc. (NASDAQ:CBPO) - Investor Newswire
06/08/16 11:37 AMChina Biologic Products, Inc. (NASDAQ:CBPO) Updated Price Targets - FTSE News
06/07/16 07:07 AMChina Biologic Products, Inc. breached its 50 day moving average in a Bullish Manner : CBPO-US : June 7, 2016 -
06/06/16 03:33 PMCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial -
06/06/16 02:55 PMNotable Stocks within Investor Radar China Biologic Products, Inc. (NASDAQ:CBPO) , Molina Healthcare Inc (NYSE ... - Street Updates
06/04/16 03:03 PMChina Biologic Products announces secondary offering of commonstock - DEALSTREETASIA
06/04/16 11:37 AMStocks Earnings Report: China Biologic Products, Inc. (NASDAQ:CBPO), The Hershey Company (NYSE:HSY) - Beacon Chronicle
06/03/16 09:12 PMBuy, Sell Or Hold Rating For China Biologic Products, Inc. (NASDAQ:CBPO)? - Share Trading News
06/03/16 11:45 AMIs Selling Stock Like China Biologic Products Inc After Such Decline Winning Strategy? - HNN
06/02/16 09:11 PMChina Biologic Products (CBPO) Announces 2.78M Common Stock Secondary Offering for Warburg Pincus, Subsidiaries - StreetInsider.com - China Biologic Products (CBPO) Announces 2.78M Common Stock Secondary Offering for Warburg Pincus, SubsidiariesStreetInsider.comChina Biologic Products, Inc. (Nasdaq: CBPO) announced that Warburg Pincus Private Equity X, L.P. ("WP X"), Warburg Pincus X Partners, L.P. ("WPP X") and WP X Biologics LLC (together with WP X and WPP X, the "Selling Stockholders") agreed to sell ...Analyst Coverage: China Biologic Products, Inc. (NASDAQ:CBPO)Risers & FallersRudman Errol M Decreased Stake in China Biologic Prods INC (NASDAQ:CBPO) by $5.12 Million as Shares DeclinedCCH Daily Newsall 3 news articles »
06/02/16 04:15 PMChina Biologic Announces Secondary Offering of Common Stock - [at noodls] - BEIJING, June 2, 2016/PRNewswire / -- China Biologic Products, Inc. (NASDAQ: CBPO, 'China Biologic' or the 'Company'), a leading plasma-based biopharmaceutical company in China, today announced that Warburg ...
06/02/16 03:55 PM4:55 pm China Biologic Products announces secondary offering by selling shareholders of ~2.78 mln common shares in an underwritten public offering -
06/02/16 03:16 PMRudman Errol M Decreased Stake in China Biologic Prods INC (NASDAQ:CBPO) by $5.12 Million as Shares Declined - CCH Daily News - Rudman Errol M Decreased Stake in China Biologic Prods INC (NASDAQ:CBPO) by $5.12 Million as Shares DeclinedCCH Daily NewsThe stock is down 2.49% or $2.91 after the negative news, hitting $114.08 per share. About 133,316 shares traded hands. China Biologic Products Inc (NASDAQ:CBPO) has risen 7.28% since October 26, 2015 and is uptrending. It has outperformed by 5.92% ...and more »
06/02/16 03:16 PMRudman Errol M Decreased Stake in China Biologic Prods INC (NASDAQ:CBPO) by $5.12 Million as Shares Declined - CCH Daily News - Rudman Errol M Decreased Stake in China Biologic Prods INC (NASDAQ:CBPO) by $5.12 Million as Shares DeclinedCCH Daily NewsThe stock is down 2.49% or $2.91 after the negative news, hitting $114.08 per share. About 133,316 shares traded hands. China Biologic Products Inc (NASDAQ:CBPO) has risen 7.28% since October 26, 2015 and is uptrending. It has outperformed by 5.92% ...and more »
05/31/16 10:28 AMMacro Factors to Look for When Investing in China -
05/23/16 03:54 PMETF’s with exposure to China Biologic Products, Inc. : May 23, 2016 -
05/22/16 01:24 PMChina Biologic Products, Inc. (NASDAQ:CBPO) Broker Price Targets For The Coming Week - Share Trading News - China Biologic Products, Inc. (NASDAQ:CBPO) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of China Biologic Products, Inc. (NASDAQ:CBPO). The latest reports which are currently in issue on Sunday 22nd of May state 0 analysts have a rating of “strong buy”, 0 ...
05/21/16 11:52 AMChina Biologic Products, Inc. (NASDAQ:CBPO) Updated Broker Price Targets - Share Trading News - China Biologic Products, Inc. (NASDAQ:CBPO) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of China Biologic Products, Inc. (NASDAQ:CBPO). The latest reports which are currently in issue on Friday 20th of May state 0 analysts have a rating of “strong buy”, 0 ...
05/17/16 12:53 PMChina Biologic Products: An Alternative To The U.S Sector - I will hold CBPO for another year or two because I am confident in this company's market and its unique position within it. I believe China Biologic Products Inc is a good company, but I take everything in their financial statements with a grain of salt ...
05/14/16 06:13 AMChina Biologic Products Inc (NASDAQ:CBPO) Sentiment Worsened, Because Uptrend - Wall Street Hints and News - China Biologic Products Inc (NASDAQ:CBPO) Sentiment Worsened, Because UptrendWall Street Hints and NewsChina Biologic Products Inc (NASDAQ:CBPO) institutional sentiment decreased to 0.74 in Q4 2015. Its down -0.18, from 0.92 in 2015Q3. The ratio turned negative, as 48 institutional investors started new or increased stock positions, while 65 decreased ...
05/11/16 05:54 AMConsensus Rating Review for China Biologic Products, Inc. (NASDAQ:CBPO) - B.O.D.Y Confidential - Consensus Rating Review for China Biologic Products, Inc. (NASDAQ:CBPO)B.O.D.Y ConfidentialEquity research analysts currently have a consensus rating of 1 on shares of China Biologic Products, Inc. (NASDAQ:CBPO). Sell-side analysts will typically rate a company's stock based on extensive research. These ratings usually translate into a Buy ...and more »
05/10/16 09:48 AMChina Biologic Products, Inc. :CBPO-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/10/16 07:22 AMChina Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : May 10, 2016 -
05/06/16 06:23 AMEarnings Outlook on China Biologic Products, Inc. (NASDAQ:CBPO) - B.O.D.Y Confidential - Earnings Outlook on China Biologic Products, Inc. (NASDAQ:CBPO)B.O.D.Y ConfidentialAnalysts and investors will be anticipating China Biologic Products, Inc. (NASDAQ:CBPO)'s next earnings release which is expected to be posted on or around 2016-05-04. Sell-side research firms on Wall Street are expecting that the company will post EPS ...and more »
05/05/16 10:31 AMEdited Transcript of CBPO earnings conference call or presentation 5-May-16 11:30am GMT -
05/04/16 11:01 PM[$$] China Biologic Is Out For Blood and Lots of It - [at Barrons.com] - Biotech stocks have been hazardous to investors’ wealth in 2016, but China Biologic Products is one to watch as strong demand for its life-saving products is expected to drive double digit earnings growth. U.S.-listed China Biologic Products (CBPO) is the top privately-owned maker of blood plasma-based pharmaceuticals in China.
05/04/16 04:31 PMCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 8-K, Results of Operations and Financial Condition -
05/04/16 04:21 PMChina Biologic Reports Financial Results for the First Quarter of 2016 - [at noodls] - BEIJING, May 4, 2016/PRNewswire / -- China Biologic Products, Inc. (NASDAQ: CBPO, 'China Biologic' or the 'Company'), a leading fully integrated plasma-based biopharmaceutical company in China, today announced ...
05/04/16 03:58 PMCHINA BIOLOGIC PRODUCTS, INC. Files SEC form 10-Q, Quarterly Report -
05/04/16 06:07 AMQ1 2016 China Biologic Products Inc Earnings Release - After Market Close -
05/04/16 05:20 AMAverage Analyst Rating for China Biologic Products, Inc. (NASDAQ:CBPO) - B.O.D.Y Confidential - Average Analyst Rating for China Biologic Products, Inc. (NASDAQ:CBPO)B.O.D.Y ConfidentialWall Street analysts have provided an average broker recommendation of 1 on China Biologic Products, Inc. (NASDAQ:CBPO) shares. The rating is determined by using the average of all analyst recommendations taken into consideration by Zacks Research.and more »
05/04/16 05:20 AMHow Analysts Rated China Biologic Products Inc (NASDAQ:CBPO) Last Week? - B.O.D.Y Confidential - How Analysts Rated China Biologic Products Inc (NASDAQ:CBPO) Last Week?B.O.D.Y ConfidentialOut of 7 analysts covering China Biologic Products (NASDAQ:CBPO), 6 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 86% are positive. China Biologic Products has been the topic of 2 analyst reports since September 4, 2015 according to ...
05/02/16 04:00 PMChina's Blood Shortages Pump Life Into $16 Billion Drugmaker -
04/27/16 07:07 AMChina Biologic Products, Inc. (NASDAQ:CBPO) Share Rating Recap - B.O.D.Y Confidential - China Biologic Products, Inc. (NASDAQ:CBPO) Share Rating RecapB.O.D.Y ConfidentialShares of China Biologic Products, Inc. (NASDAQ:CBPO) are tracked by analysts as well as crowd investors. Research from Beta Systems keeps track of crowd sourced sentiment and provides consensus stock ratings. The rating information comes mainly ...
04/27/16 07:07 AMLatest Analyst Reports On China Biologic Products, Inc. - Risers & Fallers - Latest Analyst Reports On China Biologic Products, Inc.Risers & Fallers09/03/2014 – China Biologic Products, Inc. had its “buy” rating reiterated by analysts at Aegis Capital. They now have a USD 59 price target on the stock. China Biologic Products, Inc. has a 50 day moving average of 116.90 and a 200 day moving average ...
04/26/16 06:45 AMAre Analysts Bullish China Biologic Products Inc (NASDAQ:CBPO) After Last Week? - The Post - Web Breaking NewsAre Analysts Bullish China Biologic Products Inc (NASDAQ:CBPO) After Last Week?The PostOut of 7 analysts covering China Biologic Products (NASDAQ:CBPO), 6 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 86% are positive. China Biologic Products has been the topic of 2 analyst reports since September 4, 2015 according to ...Granite Point Capital Management L.P. Decreases Position in China Biologic Products Inc (CBPO)Web Breaking Newsall 2 news articles »
04/22/16 07:47 AMChina Biologic Products to Report First Quarter 2016 Financial Results - [at noodls] - BEIJING, April 22, 2016/PRNewswire / -- China Biologic Products, Inc. (NASDAQ: CBPO, 'China Biologic' or the 'Company'), a leading fully integrated plasma-based biopharmaceutical company in China, today ...
04/20/16 07:27 AMLatest Analyst Ratings For China Biologic Products, Inc. (NASDAQ:CBPO) - Share Trading News - Latest Analyst Ratings For China Biologic Products, Inc. (NASDAQ:CBPO)Share Trading News01/07/2016 – China Biologic Products, Inc. had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 162 price target on the stock. 07/09/2015 – Bank of America Merrill Lynch began new coverage on China Biologic Products, Inc.
04/19/16 07:05 AMChina Biologic Products, Inc. (NASDAQ:CBPO) Analyst Rating Review - Clinton Financial - China Biologic Products, Inc. (NASDAQ:CBPO) Analyst Rating ReviewClinton FinancialCovering analysts typically give Buy, Sell and Hold recommendations along with guidance and company earnings projections. Currently, there are 2 analysts that have provided ratings for China Biologic Products, Inc. (NASDAQ:CBPO). 3 have rated the stock ...and more »
04/19/16 07:05 AMWere Analysts Bullish China Biologic Products Inc (NASDAQ:CBPO) This Week? - RiversideGazette.com - Were Analysts Bullish China Biologic Products Inc (NASDAQ:CBPO) This Week?RiversideGazette.comOut of 7 analysts covering China Biologic Products (NASDAQ:CBPO), 0 rate it “Buy”, 0 “Sell”, while 0 “Hold”. This means NaN are positive. China Biologic Products was the topic in 2 analyst reports since September 4, 2015 according to StockzIntelligence ...Zacks Investment Research Upgrades China Biologic Products Inc (CBPO) to "Hold"Web Breaking Newsall 2 news articles »
About China Biologic Products

China Biologic Products logoChina Biologic Products, Inc. (China Biologic) is a biopharmaceutical company. The Company is principally engaged in the research, development, manufacturing and sales of human plasma-based biopharmaceutical products in China. It operates in the manufacture and sales of human plasma products segment. It has a product portfolio with over 20 various dosage forms of plasma products and other biopharmaceutical products across over nine categories. Its principal products are human albumin and immunoglobulin for intravenous injection (IVIG). China Biologic operates its business through approximately two subsidiaries, namely, Shandong Taibang Biological Products Co. Ltd. and Guizhou Taibang Biological Products Co., Ltd. The Company also holds an interest in Xi'an Huitian Blood Products Co., Ltd., a plasma products company. Its products also include Human rabies immunoglobulin, Human tetanus immunoglobulin, Placenta polypeptide, Factor VIII and Human prothrombin complex concentrate.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CBPO
  • CUSIP:
Key Metrics:
  • Previous Close: $101.69
  • 50 Day Moving Average: $113.64
  • 200 Day Moving Average: $118.88
  • P/E Ratio: 30.42
  • P/E Growth: 1.25
  • Market Cap: $2.70B
  • Current Quarter EPS Consensus Estimate: $4.28 EPS
Additional Links:
China Biologic Products (NASDAQ:CBPO) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha